PHARMACOECONOMIC ASSESSMENT OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN IMMUNIZATION OF CHILDREN IN RUSSIAN FEDERATION

PHARMACOECONOMIC ASSESSMENT OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN IMMUNIZATION OF CHILDREN IN RUSSIAN FEDERATION

Aim: cost-effectiveness assessment and budget impact analysis for 13-valent pneumococcal conjugate vaccine (PCV13) in infant immunization program in Russian Federation. Materials and methods: 10 year modeling with social perspective (direct medical and indirect costs and life expectancy with discoun...

Full description

Saved in:
Bibliographic Details
Main Authors: ​A. V. Rudakova, A. A. Baranov, Yu. V. Lobzin, N. I. Briko, L. S. Namazova-Baranova, V. K. Tatochenko, S. M. Kharit, S. V. Sidorenko, I. S. Koroleva, R. S. Kozlov, N. A. Mayanskii, M. P. Kostinov, N. F. Snegova
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2014-01-01
Series:Вопросы современной педиатрии
Subjects:
pneumococcal diseases
13-valent pneumococcal conjugate vaccine
cost-effectiveness
budget impact analysis
Online Access:https://vsp.spr-journal.ru/jour/article/view/226
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://vsp.spr-journal.ru/jour/article/view/226

Similar Items